Targeted Therapies for Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit
About this episode
This episode discusses targeted therapies for non-small cell lung cancer with insights from Dr. Bazhenova and Dr. Langer.
Featuring perspectives from Dr Lyudmila Bazhenova and Dr Corey J Langer, including the following topics: Introduction (0:00) Therapeutic Approaches Targeting HER2 and RET — Dr Bazhenova (9:09) Therapeutic Approaches Targeting ALK and ROS1 — Dr Langer (31:56) CME information and select publications
More episodes of Lung Cancer Update
- HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review
- Nonmetastatic Non-Small Cell Lung Cancer — An Interview with Dr Jamie E Chaft
- For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress
- EGFR-Mutated Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit
- First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck
Explore listener stats, chart rankings, contacts and more on the Lung Cancer Update podcast page.